8-K 1 d542880d8k.htm FORM 8-K Form 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of Earliest Event Reported): May 20, 2013 (May 16, 2013)

 

 

Universal Biosensors, Inc.

(Exact Name of Issuer as Specified in Charter)

 

 

 

DELAWARE   000-52607   98-0424072

(State or Other Jurisdiction of

Incorporation or Organization)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification Number)

 

1 Corporate Avenue, Rowville, 3178, Victoria

Australia

  Not Applicable
(Address of Principal Executive Offices)   (Zip Code)

+61 3 9213 9000

(Registrant’s Telephone Number, Including Area Code)

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act

 

 

 


Item 5.07 Submission of Matters to a Vote of Security Holders.

Universal Biosensors, Inc (the “Company”) held its annual meeting of stockholders on May 16, 2013. At the meeting, the Company’s stockholders (i) elected the Board’s nominee (Marshall Heinberg) to serve as director of the Company until the 2016 annual meeting of stockholders, or until his successor is duly elected and qualified, (ii) approved the named senior executive compensation and (iii) authorized and approved the grant of 37,500 zero exercise price employee options to acquire shares of common stock (ZEPOs) and 917 restricted shares of common stock to the Company’s Chief Executive Officer and director, Paul Wright (the CEO).

 

1. Election of Directors    For      Against      Abstained  

Marshall Heinberg

     97,052,179         355,360         13,253   

 

2. Approval of named senior executive compensation    For      Against      Abstained  
     96,358,771         827,910         234,111   

 

3. Approval of grant of ZEPOs and restricted shares of common stock to the CEO    For      Against      Abstained  
     96,515,467         895,325         10,000   

There were no broker non-votes for any of the matters listed above.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    UNIVERSAL BIOSENSORS, INC.
Date: May 16, 2013     By:  

/s/ Paul Wright

      Name:   Paul Wright
      Title:   Chief Executive Officer